Dibyadyuti Datta1, Andrea L Conroy1, Peter F Castelluccio2, John M Ssenkusu3, Gregory S Park4, Robert O Opoka5, Paul Bangirana6, Richard Idro5, Andrew J Saykin7, Chandy C John1,4. 1. Department of Pediatrics, Ryan White Center for Pediatric Infectious Disease and Global Health, Indianapolis. 2. Department of Biostatistics, Indiana University School of Medicine, Indianapolis. 3. Department of Epidemiology and Biostatistics, Makerere University, Kampala, Uganda. 4. University of Minnesota Medical School, Minneapolis. 5. Departments of Paediatrics and Child Health, Kampala, Uganda. 6. Departments of Psychiatry, Makerere University, Kampala, Uganda. 7. Indiana Alzheimer Disease Center and Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis.
Abstract
BACKGROUND: Elevated concentrations of cerebrospinal fluid (CSF) tau, a marker of axonal injury, have been associated with coma in severe malaria (cerebral malaria [CM]). However, it is unknown whether axonal injury is related to long-term neurologic deficits and cognitive impairment in children with CM. METHODS: Admission CSF tau concentrations were measured in 145 Ugandan children with CM and compared to clinical and laboratory factors and acute and chronic neurologic and cognitive outcomes. RESULTS: Elevated CSF tau concentrations were associated with younger age, increased disease severity (lower glucose and hemoglobin concentrations, malaria retinopathy, acute kidney injury, and prolonged coma duration, all P < .05), and an increased CSF:plasma albumin ratio, a marker of blood-brain barrier breakdown (P < .001). Admission CSF tau concentrations were associated with the presence of neurologic deficits at hospital discharge, and at 6, 12, and 24 months postdischarge (all P ≤ .02). After adjustment for potential confounding factors, elevated log10-transformed CSF tau concentrations correlated with worse cognitive outcome z scores over 2-year follow-up for associative memory (β coefficient, -0.31 [95% confidence interval [CI], -.53 to -.10]) in children <5 years of age, and for overall cognition (-0.69 [95% CI, -1.19 to -.21]), attention (-0.78 [95% CI, -1.34 to -.23]), and working memory (-1.0 [95% CI, -1.68 to -.31]) in children ≥5 years of age (all P < .006). CONCLUSIONS: Acute axonal injury in children with CM is associated with long-term neurologic deficits and cognitive impairment. CSF tau concentrations at the time of the CM episode may identify children at high risk of long-term neurocognitive impairment.
BACKGROUND: Elevated concentrations of cerebrospinal fluid (CSF) tau, a marker of axonal injury, have been associated with coma in severe malaria (cerebral malaria [CM]). However, it is unknown whether axonal injury is related to long-term neurologic deficits and cognitive impairment in children with CM. METHODS: Admission CSF tau concentrations were measured in 145 Ugandan children with CM and compared to clinical and laboratory factors and acute and chronic neurologic and cognitive outcomes. RESULTS: Elevated CSF tau concentrations were associated with younger age, increased disease severity (lower glucose and hemoglobin concentrations, malaria retinopathy, acute kidney injury, and prolonged coma duration, all P < .05), and an increased CSF:plasma albumin ratio, a marker of blood-brain barrier breakdown (P < .001). Admission CSF tau concentrations were associated with the presence of neurologic deficits at hospital discharge, and at 6, 12, and 24 months postdischarge (all P ≤ .02). After adjustment for potential confounding factors, elevated log10-transformed CSF tau concentrations correlated with worse cognitive outcome z scores over 2-year follow-up for associative memory (β coefficient, -0.31 [95% confidence interval [CI], -.53 to -.10]) in children <5 years of age, and for overall cognition (-0.69 [95% CI, -1.19 to -.21]), attention (-0.78 [95% CI, -1.34 to -.23]), and working memory (-1.0 [95% CI, -1.68 to -.31]) in children ≥5 years of age (all P < .006). CONCLUSIONS: Acute axonal injury in children with CM is associated with long-term neurologic deficits and cognitive impairment. CSF tau concentrations at the time of the CM episode may identify children at high risk of long-term neurocognitive impairment.
Authors: Isabelle M Medana; Ralf-Björn Lindert; Ulrich Wurster; Tran Tinh Hien; Nicholas P J Day; Nguyen Hoan Phu; Nguyen Thi Hoang Mai; Ly Van Chuong; Tran Thi Hong Chau; Gareth D H Turner; Jeremy J Farrar; Nicholas J White Journal: Trans R Soc Trop Med Hyg Date: 2005-08 Impact factor: 2.184
Authors: Frank P Zemlan; Edward C Jauch; J Jeffery Mulchahey; S Prasad Gabbita; William S Rosenberg; Samuel G Speciale; Mario Zuccarello Journal: Brain Res Date: 2002-08-23 Impact factor: 3.252
Authors: Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin Journal: Pediatrics Date: 2008-06-09 Impact factor: 7.124
Authors: Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng Journal: Virulence Date: 2012-03-01 Impact factor: 5.882
Authors: Dag Holmberg; Elisabeth Franzén-Röhl; Richard Idro; Robert O Opoka; Paul Bangirana; Carl M Sellgren; Ronny Wickström; Anna Färnert; Lilly Schwieler; Göran Engberg; Chandy C John Journal: Malar J Date: 2017-07-28 Impact factor: 2.979
Authors: Paul Bangirana; Chandy C John; Richard Idro; Robert O Opoka; Justus Byarugaba; Anne M Jurek; Michael J Boivin Journal: PLoS One Date: 2009-11-19 Impact factor: 3.240
Authors: Benson J Ouma; Paul Bangirana; John M Ssenkusu; Dibyadyuti Datta; Robert O Opoka; Richard Idro; Kevin C Kain; Chandy C John; Andrea L Conroy Journal: Malar J Date: 2021-01-06 Impact factor: 2.979
Authors: Damalie Nalwanga; Victor Musiime; Paul Bangirana; Erika Phelps Nishiguchi; Andrew Kiggwe; Titus Ssesanga; John M Ssenkusu; Philippa Musoke; Sarah E Cusick Journal: BMC Pediatr Date: 2021-04-26 Impact factor: 2.125
Authors: Dibyadyuti Datta; Paul Bangirana; Robert O Opoka; Andrea L Conroy; Katrina Co; Caitlin Bond; Yi Zhao; Keisuke Kawata; Andrew J Saykin; Chandy C John Journal: JAMA Netw Open Date: 2021-12-01
Authors: Ruth Namazzi; Anthony Batte; Robert O Opoka; Paul Bangirana; Andrew L Schwaderer; Zachary Berrens; Dibyadyuti Datta; Michael Goings; John M Ssenkusu; Stuart L Goldstein; Chandy C John; Andrea L Conroy Journal: EClinicalMedicine Date: 2022-02-12
Authors: Elizabeth M Fernander; Pontian Adogamhe; Dibyadyuti Datta; Caitlin Bond; Yi Zhao; Paul Bangirana; Andrea L Conroy; Robert O Opoka; Chandy C John Journal: Pathog Immun Date: 2022-06-23
Authors: Anthony Batte; Zachary Berrens; Kristin Murphy; Ivan Mufumba; Maithri L Sarangam; Michael T Hawkes; Andrea L Conroy Journal: Int J Nephrol Renovasc Dis Date: 2021-07-08
Authors: Steven T DeKosky; Patrick M Kochanek; Alex B Valadka; Robert S B Clark; Sherry H-Y Chou; Alicia K Au; Christopher Horvat; Ruchira M Jha; Rebekah Mannix; Stephen R Wisniewski; Max Wintermark; Susan E Rowell; Robert D Welch; Lawrence Lewis; Stacey House; Rudolph E Tanzi; Darci R Smith; Amy Y Vittor; Nancy D Denslow; Michael D Davis; Olena Y Glushakova; Ronald L Hayes Journal: J Neurotrauma Date: 2020-11-11 Impact factor: 5.269